Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Table 4

Aggregates content obtained by SE-UPLC. Variation is presented as confidence interval at 95% ( = 3).

Product	Batch	Aggregates (%)
MabThera	B62222	0.11 ± 0.01
	H0605	0.07 ± 0.01
	N3518	0.09 ± 0.02
Kikuzubam	5445131015	0.13 ± 0.03
	5445130608	0.10 ± 0.05
	5445131216	0.25 ± 0.03